Por: RTTNews Health November 14, 2022
Biopharmaceutical company Protalix BioTherapeutics, Inc. () announced Monday the resubmission on Wednesday of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for PRX-102 (pegunigalsidase alfa) for the treatment of adult patients with Fabry disease.Pegunigalsidase alfa is a purposefully-designed, long-acting recombinant, PEGylated, cross-linked a-galactosidase-A investigational product candidate.The BLA... + full article
Forbes USA Business October 20, 2022
Valtteri Bottas of Finland and Alfa Romeo F1 looks on from the drivers parade prior to the F1 Grand ... [+] Prix of Japan at Suzuka International Racing Course. (Photo by Mark Thompson/Getty Images )Getty Images When Valtteri Bottas announced he was joining Alfa Romeo F1 Team... + más
Challenging Formula One Driver Valtteri Bottas In The SBT GRVL Bike Race | Forbes
Zhou to stay with Alfa Romeo in 2023 | ESPN
ABC News USA Health September 30, 2022
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ALS drug wins FDA approval despite questionable data | WPLG Local 10
New York Post USA Life September 30, 2022
A much-debated drug for Lou Gehrig’s disease won US approval on Thursday from the Food and Drug Administration. The nod represents a long-desired victory for patients, though it is likely to renew questions about the scientific rigor behind government reviews of... + más
ALS drug wins FDA approval despite questionable data | ABC News
ALS drug gets FDA approval despite uncertainty about effectiveness | ABC7
10 WBNS USA Nation September 30, 2022
WASHINGTON — A for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines. The Food and Drug Administration approved the drug from... + más
WPLG Local 10 USA Politics September 30, 2022
WASHINGTON – A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
Associated Press USA Science September 30, 2022
WASHINGTON (AP) — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration... + más
RTTNews USA Health September 29, 2022
Genetic medicine maker Sarepta Therapeutics, Inc. () announced Thursday that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the accelerated approval of SRP-9001 (delandistrogene moxeparvovec) to treat ambulant patients... + más
Diageo Debuts Its 2022 Special Releases Collection | Forbes
Parents of son diagnosed with Duchenne muscular dystrophy are hopeful cure will be found soon | ABC7
About iurex | Privacy Policy | Disclaimer |